← Eichor
Study identifier: NCT06953375 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty

Condition: Total Knee Arthroplasty · Functional Recovery · Aging  ·  Sponsor: University of Colorado, Denver

PhaseNA
Planned participants3250
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients experience dramatic quadriceps strength loss after total knee replacement, which contributes to persistent weakness and reduced long-term function after surgery. Neuromuscular electrical stimulation (NMES) reduces quadriceps weakness and improves patient function after knee replacement, but it is drastically underused in rehabilitation practice. This randomized trial will examine the effectiveness and feasibility of a comprehensive strategy for implementing neuromuscular electrical stimulation after knee replacement in two large healthcare organizations.

This description comes directly from the study's public registry record.

Talk to the study team

Maggie Givan, MA  ·  719.251.7533  ·  maggie.givan@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (3)

UCHealthAurora, Colorado, United StatesRecruiting
University of Colorado Denver, AnschutzAurora, Colorado, United StatesRecruiting
Intermountain HealthMurray, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06953375